This $648,924 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the role of mosquito extracellular vesicles (EVs) in the mosquito immune response against malaria parasites. The objective is to obtain a mechanistic understanding of how mosquito EVs function in pathogen recognition and immune cell activation/priming. The proposed experiments will...
The University of California, San Diego (UCSD) was awarded a $500,000 Project Grant from the National Science Foundation (NSF) Division of Integrative Organismal Systems under the Biological Sciences (CFDA 47.074) federal grant program. Through this three-year award beginning June 1, 2023, UCSD will investigate olfactory learning and neuromodulation in the Aedes aegypti mosquito vector. The research aims to elucidate the role of dopamine-mediated plasticity in early olfactory circuits and how...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is focused on advancing CRISPR-based genome editing strategies to manage Aedes aegypti mosquito populations and reduce the public health burden of mosquito-borne diseases like yellow fever, Zika, chikungunya, and dengue. The $441,502 award aims to address key limitations of existing CRISPR-based approaches, such as...
The National Science Foundation awarded a $500,000 Project Grant to the University of Washington under the Biological Sciences federal grant program (CFDA 47.074) to investigate olfactory learning and neuromodulation in the Aedes aegypti mosquito from June 1, 2023 to May 31, 2026. The research aims to understand how odor learning modifies mosquitoes' biting behaviors through three objectives: testing whether mosquitoes only learn certain odors corresponding to antennal lobe glomeruli tuning;...
This Project Grant award of $651,084, made by the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074), supports research to determine how microbes influence the response of their mosquito host to climate change, with a focus on the impacts on Hawaiian honeycreepers, an endangered bird species. The research aims to: Clarify the landscape-scale population dynamics of the mosquito vector Culex quinquefasciatus and its microbiome across an elevational gradient in Hawaii....
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $211,038 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to The Johns Hopkins University to investigate a new strategy for controlling mosquito populations. The research aims to target an enzyme called iodotyrosine deiodinase, which plays a role in protecting insects from the accumulation of halotyrosines that can suppress male fertility. The goal is to assess whether inhibiting this enzyme or...
This federal Cooperative Agreement award from the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program provides $999,479 to Vectech, Inc., a small disadvantaged business, to develop advanced artificial intelligence (AI) methods for automated identification of mosquito species from high-resolution images. The goal is to enable more accessible and scalable vector surveillance data collection to support public health institutions in their...
This Project Grant award from the USDA National Institute of Food and Agriculture under the Biotechnology Risk Assessment Research (BRAG) program (CFDA 10.219) provides $649,414 to the University of California, San Diego (UCSD) to develop tools and technologies for monitoring and improving the use of precision-guided sterile insect technique (PGSIT) and other CRISPR-based genetic technologies to control the spotted wing drosophila pest. Key deliverables include: A diagnostic system called...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will fund research to identify surface-exposed proteins in early mosquito-stage Plasmodium falciparum parasites and evaluate their potential as transmission-blocking vaccine (TBV) candidates. The total award amount is $3,762,999.00, with a project period from July 5, 2024 to May 31, 2029. The research will use mass...
This federal Project Grant award of $791,864, provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to identify the molecular factors that control chromatin organization and gene regulation in the human malaria parasite Plasmodium falciparum. The key objectives of the project are to elucidate the importance of long non-coding RNAs (lncRNAs) in parasite development, virulence, and...
GENERATING BETTER-TARGETED TRAINING DATA FOR COMPUTATIONAL ENHANCER DISCOVERY IN VECTOR INSECTS - VECTOR INSECTS ARE RESPONSIBLE FOR OVER 700,00 DEATHS ANNUALLY AND HUNDREDS OF BILLIONS OF DOLLARS IN ASSOCIATED ECONOMIC IMPACT. ALTHOUGH MANY VECTOR INSECT SPECIES HAVE HAD THEIR GENOMES SEQUENCED, THE REGULATORY COMPONENT OF THESE GENOMES IS LARGELY UNDEFINED. CHARACTERIZING REGULATORY SEQUENCES-IN PARTICULAR, "ENHANCERS"-IS CRITICAL FOR UNDERSTANDING THE ORGANIZATION OF GENE REGULATORY NETWORKS AND HOW THE GENOME INFORMS PHENOTYPE. ENHANCERS PLAY IMPORTANT ROLES IN MEDIATING INSECTICIDE RESISTANCE, PATHOGEN TRANSMISSION, HOST RECOGNITION, MATING SUCCESS, AND OTHER CRITICAL VECTOR-RELEVANT BIOLOGICAL PROCESSES. ENHANCERS ALSO SERVE AS MAJOR COMPONENTS OF BIOTECHNOLOGY TOOLS REQUIRING PRECISELY TARGETED GENE EXPRESSION, ADDING ADDITIONAL IMPORTANCE TO THEIR IDENTIFICATION AND CHARACTERIZATION. GIVEN THAT ENHANCERS ARE SO IMPORTANT, BUT THAT FEW INSECT ENHANCERS ARE KNOWN OTHER THAN FOR THE FRUIT FLY, DROSOPHILA MELANOGASTER, THERE IS A PRESSING NEED FOR EFFICIENT METHODS FOR ENHANCER DISCOVERY THAT CAN BE APPLIED TO A WIDE RANGE OF VECTOR SPECIES. WE PREVIOUSLY DEVELOPED "SCRMSHAW," A COMPUTATIONAL METHOD FOR ENHANCER DISCOVERY, AND USED IT TO PREDICT ENHANCERS IN OVER 36 INSECT SPECIES INCLUDING VECTOR MOSQUITOES. SCRMSHAW UTILIZES KNOWN ENHANCERS AS "TRAINING DATA" TO GUIDE ITS SEARCH FOR UNKNOWN ENHANCERS WITH RELATED FUNCTION. WE HAVE DEMONSTRATED THAT WE CAN USE DROSOPHILA ENHANCERS, OF WHICH MANY (~38,000) ARE WELL- CHARACTERIZED, AS TRAINING DATA TO DISCOVER SIMILAR ENHANCERS IN OTHER INSECT SPECIES. UNFORTUNATELY, DESPITE THIS LARGE NUMBER OF KNOWN DROSOPHILA ENHANCERS, TRAINING ENHANCERS ARE NOT AVAILABLE FOR MANY SIGNIFICANT CELL TYPES. THIS IS ESPECIALLY TRUE FOR NON-EMBRYONIC STAGES OF THE LIFE CYCLE AND CELLS OF PARTICULAR INTEREST FOR VECTOR BIOLOGY, E.G. THOSE INVOLVED IN INSECTICIDE RESISTANCE, PATHOGEN TRANSMISSION, AND REPRODUCTION. THIS PROPOSAL ADDRESSES THIS MAJOR SHORTCOMING BY DEVELOPING A NEW WAY TO GENERATE SCRMSHAW TRAINING DATA, USING SCATAC-SEQ DATA. THIS WILL OPEN UP A BROAD POTENTIAL SOURCE OF TRAINING DATA FOR CURRENTLY UNDER-STUDIED CELL TYPES, AND ENABLE PREDICTION OF ENHANCERS IN SPECIES AT GREATER EVOLUTIONARY DISTANCES FROM DROSOPHILA. IT WILL ALSO ALLOW FOR SIGNIFICANTLY IMPROVED ESTIMATION OF TRUE- AND FALSE-POSITIVE ENHANCER PREDICTION RATES. THE PROPOSED APPROACH IS RAPID; INEXPENSIVE; AND REQUIRES EMPIRICAL DATA FROM ONLY A SINGLE REPRESENTATIVE ORGANISM BUT CAN BE APPLIED TO DOZENS TO HUNDREDS OF LOOSELY-RELATED ORGANISMS. IT WILL ALLOW A SINGLE SET OF QUALITY SCATAC-SEQ EXPERIMENTS IN DROSOPHILA OR A VECTOR MOSQUITO TO BE LEVERAGED FOR ENHANCER PREDICTION IN THE MAJORITY OF VECTOR INSECT SPECIES. THIS WORK WILL THEREFORE PROVIDE IMMEDIATE IMPORTANT OUTCOMES BY ENABLING FUNCTIONAL REGULATORY ANNOTATION OF AN EXPANDED SET OF RELEVANT CELL TYPES FOR A SIGNIFICANT PORTION OF SEQUENCED VECTOR INSECTS. IT WILL HAVE A MAJOR LONG-TERM IMPACT ON OUR ABILITY TO ADDRESS FUNDAMENTAL QUESTIONS OF VECTOR BIOLOGY AND TO IMPROVE STRATEGIES FOR VECTOR CONTROL.